CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bortner, D. M.
Right arrow Articles by Rosenberg, M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bortner, D. M.
Right arrow Articles by Rosenberg, M. P.

Cell Growth & Differentiation, Vol 6, Issue 12 1579-1589, Copyright © 1995 by American Association of Cancer Research


ARTICLES

Overexpression of cyclin A in the mammary glands of transgenic mice results in the induction of nuclear abnormalities and increased apoptosis

DM Bortner and MP Rosenberg
Glaxo Wellcome, Inc., Research Triangle Park, North Carolina 27709, USA.

Aberrant expression of several cyclin genes has been demonstrated to be associated with many types of tumors. To determine the capacity of cyclin A to function as an oncogene in vivo, wild-type and mutant cyclin A proteins were specifically overexpressed in the mammary glands of transgenic mice using regulatory sequences from the ovine beta-lactoglobulin gene. Several lines of transgenic mice were generated that expressed human cyclin A or a nondegradable mutant version of human cyclin A, in which the amino-terminal 89 amino acids encompassing the cyclin destruction box were removed. The cyclin A transgene products were localized in the nuclei of mammary epithelial cells, and the transgenic mammary glands had an increase in cyclin A- and cdk2-associated H1 kinase activity. Many mammary epithelial cells in the transgenic glands exhibited nuclear abnormalities, including multinucleation and karyomegaly, which were suggestive of preneoplastic alterations. The abnormalities were more severe in mammary glands of the mutant cyclin A transgenics, which expressed a stabilized cyclin A protein. In situ analysis of mid-lactation mammary gland sections revealed increased numbers of apoptotic cells in the transgenic glands. Double transgenic animals were generated that expressed both the mutant human cyclin A and human cdk2 transgenes, and a more pronounced phenotype resulted. The bigenic mammary glands exhibited focal areas of hyperplasia, as well as a greater incidence of apoptosis than observed in the single transgenic glands, demonstrating in vivo cooperation between these genes in transformation and apoptotic signaling pathways.


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Zhao, R. W. Deibler, P. H. Lerou, A. Ballabeni, G. C. Heffner, P. Cahan, J. J. Unternaehrer, M. W. Kirschner, and G. Q. Daley
A nontranscriptional role for Oct4 in the regulation of mitotic entry
PNAS, November 4, 2014; 111(44): 15768 - 15773.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. J. Russo, P. G. Magro, Z. Hu, W.-W. Li, R. Peters, J. Mandola, D. Banerjee, and J. R. Bertino
E2F-1 Overexpression in U2OS Cells Increases Cyclin B1 Levels and cdc2 Kinase Activity and Sensitizes Cells to Antimitotic Agents.
Cancer Res., July 15, 2006; 66(14): 7253 - 7260.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Sugaya, T. Watanabe, A. Yang, M. F. Starost, H. Kobayashi, A. M. Atkins, D. L. Borris, E. A. Hanan, D. Schimel, M. A. Bryant, et al.
Lymphatic dysfunction in transgenic mice expressing KSHV k-cyclin under the control of the VEGFR-3 promoter
Blood, March 15, 2005; 105(6): 2356 - 2363.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. H. Shen, S. T. Jackson, S. R. Broussard, R. H. McCusker, K. Strle, G. G. Freund, R. W. Johnson, R. Dantzer, and K. W. Kelley
IL-1{beta} Suppresses Prolonged Akt Activation and Expression of E2F-1 and Cyclin A in Breast Cancer Cells
J. Immunol., June 15, 2004; 172(12): 7272 - 7281.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
W. H. Shen, Y. Yin, S. R. Broussard, R. H. McCusker, G. G. Freund, R. Dantzer, and K. W. Kelley
Tumor Necrosis Factor {alpha} Inhibits Cyclin A Expression and Retinoblastoma Hyperphosphorylation Triggered by Insulin-like Growth Factor-I Induction of New E2F-1 Synthesis
J. Biol. Chem., February 27, 2004; 279(9): 7438 - 7446.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. Balmanno, T. Millar, M. McMahon, and S. J. Cook
{Delta}Raf-1:ER* Bypasses the Cyclic AMP Block of Extracellular Signal-Regulated Kinase 1 and 2 Activation but Not CDK2 Activation or Cell Cycle Reentry
Mol. Cell. Biol., December 15, 2003; 23(24): 9303 - 9317.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. Holzschu, L. A. Lapierre, and M. D. Lairmore
Comparative Pathogenesis of Epsilonretroviruses
J. Virol., December 1, 2003; 77(23): 12385 - 12391.
[Full Text] [PDF]


Home page
J Biol ChemHome page
K. Jurchott, S. Bergmann, U. Stein, W. Walther, M. Janz, I. Manni, G. Piaggio, E. Fietze, M. Dietel, and H.-D. Royer
YB-1 as a Cell Cycle-regulated Transcription Factor Facilitating Cyclin A and Cyclin B1 Gene Expression
J. Biol. Chem., July 18, 2003; 278(30): 27988 - 27996.
[Abstract] [Full Text] [PDF]


Home page
EMBO J.Home page
P. F. de Borja, N. K. Collins, P. Du, J. Azizkhan-Clifford, and M. Mudryj
Cyclin A-CDK phosphorylates Sp1 and enhances Sp1-mediated transcription
EMBO J., October 15, 2001; 20(20): 5737 - 5747.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
F. Zhao, A. Vilardi, R. J. Neely, and J. K. Choi
Promotion of Cell Cycle Progression by Basic Helix-Loop-Helix E2A
Mol. Cell. Biol., September 15, 2001; 21(18): 6346 - 6357.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H.-M. Koo, M. J. McWilliams, W. G. Alvord, and G. F. Vande Woude
Ras Oncogene-Induced Sensitization to 1-{{beta}}-D-Arabinofuranosylcytosine
Cancer Res., December 1, 1999; 59(24): 6057 - 6062.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
K. S. Choi, Y. W. Eom, Y. Kang, M. J. Ha, H. Rhee, J.-W. Yoon, and S.-J. Kim
Cdc2 and Cdk2 Kinase Activated by Transforming Growth Factor-{beta}1 Trigger Apoptosis through the Phosphorylation of Retinoblastoma Protein in FaO Hepatoma Cells
J. Biol. Chem., November 5, 1999; 274(45): 31775 - 31783.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
W. Li, J. Fan, D. Banerjee, and J. R. Bertino
Overexpression of p21waf1 Decreases G2-M Arrest and Apoptosis Induced by Paclitaxel in Human Sarcoma Cells Lacking Both p53 and Functional Rb Protein
Mol. Pharmacol., June 1, 1999; 55(6): 1088 - 1093.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
V. Reinke, D. M. Bortner, L. L. Amelse, K. Lundgren, M. P. Rosenberg, C. A. Finlay, and G. Lozano
Overproduction of MDM2 in Vivo Disrupts S Phase Independent of E2F1
Cell Growth Differ., March 1, 1999; 10(3): 147 - 154.
[Abstract] [Full Text]


Home page
Genes Dev.Home page
K Lundgren, R Montes de Oca Luna, Y B McNeill, E P Emerick, B Spencer, C R Barfield, G Lozano, M P Rosenberg, and C A Finlay
Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53.
Genes & Dev., March 15, 1997; 11(6): 714 - 725.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1995 by the American Association of Cancer Research.